Dysliptin C Tablet 10’S

Name: Dysliptin C Tablet 10'S
SKU: bp/med/547
Availability: InStock

0 customer reviews Sold: 0

Original price was: ₹169.00.Current price is: ₹160.00.

*10 Tablet(s) in a Strip* Mkt: East West Pharma* Country of Origin: India* Delivery charges if applicable will be applied at checkou

Add to cart

Wishlist

Compare

Store

Astha medical

0 out of 5

Ask a Question

SKU: bp/med/547 Category: Medicine

Introduction About DYSLIPTIN C TABLET

DYSLIPTIN C TABLET is used to reduce elevated cholesterol and triglyceride levels in patients when a low-fat diet and lifestyle changes alone have failed. It is a combination of Atorvastatin and Clopidogrel which belongs to the group of medicines called HMG-CoA reductase inhibitors and Antiplatelet medicines respectively. It can also be used to reduce the risk of heart problems such as myocardial infarction, angina (chest pain), heart failure including stroke or revascularization procedures in adult patients with or without a clinically evident chronic heart disease.

Along with management with DYSLIPTIN C TABLET, patient should follow an appropriate lipid-lowering diet as advised by their doctor to enhance recovery. Before using the medicine, inform your doctor if you have any liver or kidney disease. Patients with active liver disease should discontinue the use of DYSLIPTIN C TABLET as it may cause serious side effects in them.

It is not recommended for use in pregnant or breastfeeding women and in patients with bleeding disorders. It is not suitable for use in children and adolescents (aged below 18 years). Avoid consumption of grapefruit juice or alcohol while taking DYSLIPTIN C TABLET as it may lead to unwanted interactions. The most common side effects are muscle pain, joint pain, diarrhoea, nausea, headache or stomach pain. Consult your doctor if any of the side effects worsen.

Uses Of DYSLIPTIN C TABLET

It is used to reduce:

elevated cholesterol and triglyceride levels in patients when a low-fat diet and lifestyle changes alone have failed

the risk of heart problems such as myocardial infarction (MI), angina, heart failure including stroke or revascularization procedures in adult patients with or without clinically evident of chronic heart disease